AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 201 filers reported holding AXSOME THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.85 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $64,019 | -2.7% | 916 | 0.0% | 0.00% | – |
| Q2 2023 | $65,824 | +128966.7% | 916 | +10.9% | 0.00% | – |
| Q1 2023 | $51 | -20.3% | 826 | 0.0% | 0.00% | -100.0% |
| Q4 2022 | $64 | -99.8% | 826 | 0.0% | 0.00% | – |
| Q3 2022 | $37,000 | +8.8% | 826 | -7.0% | 0.00% | – |
| Q2 2022 | $34,000 | +183.3% | 888 | +208.3% | 0.00% | – |
| Q1 2022 | $12,000 | -78.9% | 288 | -86.1% | 0.00% | – |
| Q4 2021 | $57,000 | +256.2% | 2,078 | +324.1% | 0.00% | – |
| Q3 2021 | $16,000 | -91.1% | 490 | -81.7% | 0.00% | -100.0% |
| Q2 2021 | $180,000 | +9.1% | 2,671 | -8.6% | 0.00% | 0.0% |
| Q1 2021 | $165,000 | -30.7% | 2,921 | 0.0% | 0.00% | -50.0% |
| Q4 2020 | $238,000 | +95.1% | 2,921 | +70.3% | 0.00% | +100.0% |
| Q3 2020 | $122,000 | -41.1% | 1,715 | -31.7% | 0.00% | -50.0% |
| Q2 2020 | $207,000 | +1492.3% | 2,512 | +1041.8% | 0.00% | – |
| Q1 2020 | $13,000 | -58.1% | 220 | -26.7% | 0.00% | – |
| Q4 2019 | $31,000 | +416.7% | 300 | 0.0% | 0.00% | – |
| Q3 2019 | $6,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 788,263 | $35,172,000 | 44.43% |
| Fairmount Funds Management LLC | 1,896,647 | $84,628,000 | 14.88% |
| ACT CAPITAL MANAGEMENT, LLC | 73,000 | $3,257,000 | 4.50% |
| Ghost Tree Capital, LLC | 300,000 | $13,386,000 | 3.76% |
| Ikarian Capital, LLC | 407,600 | $18,188,000 | 3.62% |
| Paradigm Biocapital Advisors LP | 520,080 | $23,206,000 | 3.09% |
| MORGAN JESS S & CO INC | 78,895 | $3,520,000 | 3.06% |
| PFM Health Sciences, LP | 1,659,733 | $74,057,000 | 2.68% |
| RTW INVESTMENTS, LP | 1,882,164 | $83,982,000 | 1.94% |
| Ghost Tree Capital, LLC | 150,000 | $6,693,000 | 1.88% |